Consun Pharmaceutical Group Limited (HKG:1681)
17.39
+0.89 (5.39%)
At close: Mar 27, 2026
HKG:1681 Revenue
In the year 2025, Consun Pharmaceutical Group had annual revenue of 3.42B CNY with 15.17% growth. Consun Pharmaceutical Group had revenue of 1.57B in the half year ending June 30, 2025, with 40.09% growth.
Revenue
3.42B CNY
Revenue Growth
+15.17%
P/S Ratio
3.85
Revenue / Employee
1.11M CNY
Employees
3,073
Market Cap
14.63B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.42B | 450.12M | 15.17% |
| Dec 31, 2024 | 2.97B | 377.12M | 14.56% |
| Dec 31, 2023 | 2.59B | 250.47M | 10.71% |
| Dec 31, 2022 | 2.34B | 294.99M | 14.43% |
| Dec 31, 2021 | 2.04B | 291.83M | 16.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| The United Laboratories International Holdings | 14.70B |
| Grand Pharmaceutical Group | 12.28B |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| Luye Pharma Group | 6.76B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| CanSino Biologics | 1.19B |
| OneRobotics (Shenzhen) | 801.23M |